Hamilton Lane (NASDAQ:HLNE) Price Target Cut to $157.00 by Analysts at Morgan Stanley

Hamilton Lane (NASDAQ:HLNE) had its target price trimmed by Morgan Stanley from $190.00 to $157.00 in a report released on Monday morning,Benzinga reports. The firm currently has an equal weight rating on the stock.

HLNE has been the topic of a number of other reports. Oppenheimer raised Hamilton Lane from a “market perform” rating to an “outperform” rating and set a $186.00 price objective on the stock in a report on Tuesday, January 21st. Wells Fargo & Company cut their price target on shares of Hamilton Lane from $152.00 to $147.00 and set an “equal weight” rating on the stock in a report on Tuesday, April 8th. The Goldman Sachs Group downgraded shares of Hamilton Lane from a “neutral” rating to a “sell” rating and set a $139.00 price objective on the stock. in a report on Monday, January 6th. Finally, Keefe, Bruyette & Woods raised their target price on shares of Hamilton Lane from $158.00 to $168.00 and gave the stock a “market perform” rating in a report on Wednesday, February 5th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and one has issued a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and an average target price of $165.29.

Hamilton Lane Stock Up 2.7 %

NASDAQ:HLNE opened at $140.87 on Monday. The company has a current ratio of 4.19, a quick ratio of 4.19 and a debt-to-equity ratio of 0.34. Hamilton Lane has a twelve month low of $108.34 and a twelve month high of $203.72. The company has a market cap of $7.81 billion, a PE ratio of 25.99 and a beta of 1.32. The company’s 50 day moving average is $149.10 and its two-hundred day moving average is $163.25.

Hamilton Lane (NASDAQ:HLNE) last posted its quarterly earnings data on Tuesday, February 4th. The company reported $1.25 EPS for the quarter, topping the consensus estimate of $1.13 by $0.12. The business had revenue of $168.26 million during the quarter, compared to the consensus estimate of $158.86 million. Hamilton Lane had a net margin of 31.12% and a return on equity of 36.69%. The business’s revenue for the quarter was up 34.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.71 earnings per share. Analysts anticipate that Hamilton Lane will post 4.97 EPS for the current year.

Hamilton Lane Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, April 4th. Stockholders of record on Friday, March 14th were paid a dividend of $0.49 per share. This represents a $1.96 annualized dividend and a dividend yield of 1.39%. The ex-dividend date was Friday, March 14th. Hamilton Lane’s payout ratio is currently 36.16%.

Hedge Funds Weigh In On Hamilton Lane

Institutional investors and hedge funds have recently modified their holdings of the business. Price T Rowe Associates Inc. MD grew its holdings in Hamilton Lane by 229.7% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 1,292,266 shares of the company’s stock valued at $191,321,000 after purchasing an additional 900,283 shares during the period. Vanguard Group Inc. lifted its position in shares of Hamilton Lane by 28.4% during the 4th quarter. Vanguard Group Inc. now owns 3,901,933 shares of the company’s stock valued at $577,681,000 after buying an additional 863,326 shares in the last quarter. Norges Bank acquired a new stake in Hamilton Lane in the 4th quarter valued at $68,909,000. Invesco Ltd. increased its holdings in Hamilton Lane by 25.3% in the 4th quarter. Invesco Ltd. now owns 1,923,253 shares of the company’s stock worth $284,738,000 after acquiring an additional 388,019 shares in the last quarter. Finally, Artemis Investment Management LLP acquired a new position in Hamilton Lane during the fourth quarter worth $30,350,000. Hedge funds and other institutional investors own 97.40% of the company’s stock.

Hamilton Lane Company Profile

Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.